C., Botros, F
Doctors were able to answer my questions, no matter how silly or crazy. And with her hectic travel schedule, she appreciated that support was just a click away, rather than having to schedule an in-person appointment at an office
Tier 2: Cardiovascular Disease and Sleep Apnea Covered in Most States (Required Since 2024) Two newer FDA approvals expanded mandatory Medicaid coverage: Wegovy for cardiovascular risk reduction FDA-approved in March 2024 to reduce the risk of heart attack, stroke, and cardiovascular death in overweight or obese adults with established cardiovascular disease
Mechanisms such as cellular senescence, genomic instability, telomere attrition, mitochondrial dysfunction, epigenetic alterations, and loss of proteostasis all contribute to an aging phenotype (Tenchov et al 2024) and are considered hallmarks or biomarkers for aging
Its also available compounded through licensed pharmacies, which is how a lot of our patients access it